Deutsch Русский About Us Products Applications Case Studies Education For Patients Get In Touch Breast and Deep Inspiration Breath Hold (DIBH) Radiation therapy has been shown to be a highly effective treatment for breast cancer. But the proximity of the left breast to the heart leaves the heart vulnerable to radiation exposure. This has been shown, in some cases, to lead to serious long-term cardiac complications¹. Many centers are beginning to have patients use Deep Inspiration Breath Hold (DIBH) to move the heart away from the breast during therapy. However, achieving this can be challenging². Patients breathe in different ways at different times and may arch their back to simulate a deep breath in. These different movements can appear similar to a patient’s true breath-hold, but do not necessarily separate the heart from the breast. AlignRT® is the only SGRT system with long-term data showing avoidance of cardiac damage in left-breast cancer patients. Get in touch to learn more about AlignRT for DIBH. Use the form on the right and let us know if you’d like to schedule a demo (virtual or in-person), receive a brochure, get a quote from a member of our sales team, or find out more about our business case and marketing support. Virtual demo Business case support E-brochures Get a quote I’d like to schedule a virtual demo for: AlignRT Advance AlignRT InBore SimRT SafeID DoseRT The different applications of AlignRT NEXT 1. Darby et al. Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. N Engl J Med 2013; 368:987-998 2. Gierga et al. A Voluntary Breath-Hold Treatment Technique for the Left Breast With Unfavorable Cardiac Anatomy Using Surface Imaging. Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e663-8 3. Zagar et al. Prospective Assessment of Deep Inspiration Breath Hold to Prevent Radiation Associated Cardiac Perfusion Defects in Patients With Left-Sided Breast Cancer J Appl Clin Med Phys. 2015 ;93:3S 2027 4. Marks, L. B. et al. The incidence and functional consequences of RT‑associated cardiac perfusion defects. Int. J. Radiat. Oncol. Biol. Phys. 63, 214–223 (2005) *This customer quote reports on clinical use and performance of Vision RT’s products by independent users. These are not validated by Vision RT and thus are not endorsed by Vision RT. Users of Vision RT’s products should develop and validate their own workflows consistent with clinical practice within their facility. Products Applications Case Studies Education Support © 2021 Vision RT Ltd. All Rights Reserved. Legal Information Privacy Policy Terms of use Clinical Information We'll assume you're OK with this, but you can change your preferences here. Cookie settingsACCEPT